SCHEMBL7160661

SCHEMBL7160661

CC(C)Oc1ccc(CCCC2OC(=O)NC2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.45
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
KDM4E B2RXH2 2/20 0.40
PPARG P37231 1/20 0.39
KDM4A O75164 1/20 0.39
MAPT P10636 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.36
ACACB O00763 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
P2RX3 P56373 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8794891 0.96 GLA (0.44) GLACYP4F2CYP4A11KDM4EPPARG
SCHEMBL8793241 0.95 GLA (0.43) GLACYP4F2CYP4A11KDM4EPPARG
SCHEMBL6583573 0.81 PPARG (0.54) PPARGMAPTMAPK1SMN1; SMN2
SCHEMBL7165615 0.78 PPARG (0.41) CYP4F2CYP4A11KDM4EPPARG
SCHEMBL6964713 0.74 GLA (0.45) GLAKDM4EPPARGMAPTPOLB
SCHEMBL7160667 0.74 GLA (0.40) GLAKDM4EKDM4AMAPTKDM4C
SCHEMBL8888011 0.74 LTA4H (0.49) CYP4F2CYP4A11
SCHEMBL8890354 0.73 MGLL (0.50) CYP4F2CYP4A11
SCHEMBL8888505 0.73 MGLL (0.50) CYP4F2CYP4A11
SCHEMBL8888854 0.73 MGLL (0.50) CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552058-B1 For therapy of diabetes or hyperlipidemia TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-22 US disclosed
US-6147099-A USEFUL AS ANTI-DIABETICS OR HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2000-11-14 US disclosed
US-5972970-A COMPOUNDS SUCH AS 5-(3-(2-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL) ETHOXYL-5-PYRIDYL)PROPYL)-2,4-OXAZOLIDINEDIONE; ADMINISTERING TO TREAT A MAMMAL SUFFERING FROM DIABETES OR HYPERLIPIDEMIA TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-10-26 US disclosed
EP-0612743-B1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-10 EP disclosed
US-5665748-A ANTIDIABETIC, HYPOLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-09 US disclosed
EP-0612743-A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-08-31 EP disclosed